IMC Chicago’s Allergan plc AGN Stock Holding History

IMC Chicago’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-26,900	Closed	-$4.76M	–	988
2020 Q1	$4.76M	Sell	26,900 -5,700	-17%	-$1.07M	0.01%	341
2019 Q4	$6.23M	Sell	32,600 -8,900	-21%	-$1.61M	0.02%	305
2019 Q3	$6.98M	Sell	41,500 -85,800	-67%	-$14M	0.02%	228
2019 Q2	$21.3M	Buy	127,300 +101,700	+397%	+$14.1M	0.07%	93
2019 Q1	$3.75M	Sell	25,600 -2,000	-7%	-$290K	0.01%	280
2018 Q4	$3.69M	Buy	+27,600	New	+$4.52M	0.01%	253

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

IMC Chicago's AGN Position: Q2 2020 in Review

IMC Chicago sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 55,238 shares — an estimated $9.78M sold.

IMC Chicago first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $9.78M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

IMC Chicago reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
IMC Chicago sold 55,238 Allergan plc shares in Q2 2020, an estimated $9.78M.
IMC Chicago first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
IMC Chicago's Allergan plc position peaked at $9.78M in Q1 2020.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on IMC Chicago's 13F filing for Q2 2020, filed 14 Aug 2020.